about
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidat...
Read More
21.96
1.21
(5.83%)
144.9K
XNAS Volume
XNAS 17 Jul, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Surrozen Inc is on 22 Jul 2026 for the purpose of H.C. Wainwright 6(th) Annual Ophthalmology Virtual Conference
See details
Not Eligible
Expensive Valuation
Technically Neutral
Surrozen Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..